Sandra Liliana Valderrama - Infectious Diseases

Author Information

Sandra Liliana Valderrama is a distinguished researcher affiliated with the Hospital Universitario San Ignacio, Department of Internal Medicine, Infectious Diseases Unit, located in Bogotá, Colombia. Her expertise lies in the field of infectious diseases, with a significant focus on antibiotic resistance, viral infections, and hospital-acquired infections. Her work is particularly impactful in understanding and managing infectious diseases in healthcare settings.

Research Contributions

Dr. Valderrama has made substantial contributions to the field of infectious diseases, evidenced by her extensive research on various critical topics. Her work includes significant studies on carbapenem-resistant Enterobacteriaceae, SARS-CoV-2/COVID-19 management, and the epidemiology of infectious agents such as Candida auris and Histoplasmosis. She has also contributed to the understanding of the clinical and microbiological characteristics of infections, as well as the prevention of hospital-acquired conditions. Her research often focuses on the Colombian context, providing valuable insights into the regional epidemiology and challenges in infectious disease management.

Aliases

Sandra Liliana Valderrama is also known by several aliases in academic publications, including Sandra L Valderrama and Sandra L. Valderrama. These variations often appear in different research articles and databases.

Publication and Citation Metrics

Metric	Value
Total Citations	373
h-index	9
Total Publications	28

Publications:

Factors associated with mortality in Infections caused by Carbapenem-resistant Enterobacteriaceae.

DOI: 10.3855/jidc.12267

Year: 2020

"Colombian consensus recommendations for diagnosis, management and treatment of the infection by SARS-COV-2/ COVID-19 in health care facilities - Recommendations from expert´s group based and informed on evidence"

DOI: 10.1001/JAMANETWORKOPEN.2020.0802

Year: 2020

Presentation of histoplasmosis as mononucleosis syndrome in an immunocompetent patient

DOI: 10.1016/j.mmcr.2019.10.007

Year: 2019

326. Is Antiretroviral Treatment Averting AIDS and non-AIDS Defining Malignancies in Colombia?

DOI: 10.1093/ofid/ofz360.399

Year: 2019

625. Genomic Epidemiology of Carbapenem-Resistant Enterobacteriaceae from Colombia: A Prospective Multicenter Study

DOI: 10.1093/ofid/ofz360.693

Year: 2019

1628. Clinical, Epidemiological and Microbiological Characterization of Invasive Streptococcus pneumoniae Disease in Hospitalized Adults from 5 Tertiary Hospitals in Bogotá, Colombia: A Descriptive Study

DOI: 10.1093/ofid/ofz360.1492

Year: 2019

Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia

DOI: 10.1186/s12866-019-1482-y

Year: 2019

First report of sporadic cases of Candida auris in Colombia.

DOI: 10.1016/j.ijid.2018.01.034

Year: 2018

1267. Nonventilator Hospital Acquired Pneumonia (NV-HAP) Prevention Initiative in Colombia, Bogotá

DOI: 10.1093/ofid/ofy210.1100

Year: 2018

Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients

DOI: 10.3389/fimmu.2018.02291

Year: 2018

Can Symptomatic Relief Replace Primary Treatment?

What are the Key Factors in Resource Allocation?

What are the common misconceptions about condoms?

How Does a PCR Test Work?

What is the Treatment for Rabies?

What is the Impact of Schistosomiasis Globally?

How is Herpes Diagnosed?

How Does Glycolysis Relate to Infectious Diseases?

What are CRISPR-Cas Systems?

How Does WHO Collaborate with Other Organizations?

Partnered Content Networks

Relevant Topics